Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
5,562
Views
15
CrossRef citations to date
0
Altmetric
COVID-19

The societal economic value of COVID-19 vaccines in the United States

Noam Kirsona Analysis Group, Inc, Boston, MA, USCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5200-6883
ORCID Icon,
Elyse Swallowa Analysis Group, Inc, Boston, MA, US
,
Jessica Lua Analysis Group, Inc, Boston, MA, US
,
Marco Mesa-Friasb Janssen Pharmaceuticals, Inc, Raritan, NJ, USORCID Iconhttps://orcid.org/0000-0002-2880-8373
ORCID Icon,
Brahim Bookhartb Janssen Pharmaceuticals, Inc, Raritan, NJ, US
,
Josie Maynarda Analysis Group, Inc, Boston, MA, US
,
Yashna Shivdasania Analysis Group, Inc, Boston, MA, US
&
Patrick Lefebvrec Analysis Group, Inc, Montreal, Quebec, Canada
 show all
Pages 119-128 | Received 15 Nov 2021, Accepted 04 Jan 2022, Published online: 20 Jan 2022

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

J. P. Sevilla. (2024) COVID-19 vaccines should be evaluated from the societal perspective. Journal of Medical Economics 27:1, pages 1-9.
Read now
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela Di Fusco, Timothy Lee Wiemken, Moe H. Kyaw, John M. McLaughlin & Jennifer L. Nguyen. (2023) Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert Review of Vaccines 22:1, pages 54-65.
Read now
Manuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, Timothy L. Wiemken, Jingyan Yang & Benjamin Yarnoff. (2023) Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States. Journal of Medical Economics 26:1, pages 509-524.
Read now
Ivo Abraham, Kenneth K. C. Lee & Mike Gregg. (2023) Journal of Medical Economics in review: high impact articles from 2022. Journal of Medical Economics 26:1, pages 303-307.
Read now
Audrey V. Adler, Haley R. Nadone, Mirabel E. Dafinone & Kevin C. Facemyer. (2023) Social justice in medical education: a student-led approach to addressing COVID-19 vaccine equity in the Hispanic/Latinx community. Medical Education Online 28:1.
Read now
Moe H. Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh & Amit Srivastava. (2023) Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human Vaccines & Immunotherapeutics 19:1.
Read now
Manuela Di Fusco, Kinga Marczell, Kristen A. Deger, Mary M. Moran, Timothy L. Wiemken, Alejandro Cane, Solène de Boisvilliers, Jingyan Yang, Shailja Vaghela & Julie Roiz. (2022) Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States. Journal of Medical Economics 25:1, pages 605-617.
Read now

Articles from other publishers (8)

Liangyuan Zhang, Jianzhou Yang, Rila Su, Xinquan Lan, Moxin Song, Lei Zhang & Junjie Xu. (2024) Willingness to receive the second booster of COVID-19 vaccine among older adults with cancer: a stratified analysis in four provinces of China. Frontiers in Public Health 12.
Crossref
Katelyn M. Sileo, Inara M. Hirani, Rebecca L. Luttinen, Matt Hayward & Paul J. Fleming. (2023) A Scoping Review on Gender/Sex Differences in COVID-19 Vaccine Intentions and Uptake in the United States. American Journal of Health Promotion 38:2, pages 242-274.
Crossref
Anna Oh, Siqi Gan, W. John Boscardin, Torsten B. Neilands, Anita L. Stewart, Tung T. Nguyen & Alexander K. Smith. (2023) Effect of the COVID ‐19 pandemic on meaningful activity engagement in racially and ethnically diverse older adults . Journal of the American Geriatrics Society 71:9, pages 2924-2934.
Crossref
Sean M. Bagshaw, Annalise Abbott, Sanjay Beesoon, Samantha L. Bowker, Danny J. Zuege & Nguyen X. Thanh. (2023) A population-based assessment of avoidable hospitalizations and resource use of non-vaccinated patients with COVID-19. Canadian Journal of Public Health.
Crossref
Yaqun Fu, Jingyu Zhao, Peien Han, Jiawei Zhang, Quan Wang, Qingbo Wang, Xia Wei, Li Yang, Tao Ren, Siyan Zhan & Liming Li. (2023) Cost‐effectiveness of COVID‐19 vaccination: A systematic review. Journal of Evidence-Based Medicine.
Crossref
Manuela Di Fusco, Diana Mendes, Lotte Steuten, David E Bloom, Michael Drummond, Katharina Hauck, Jonathan Pearson-Stuttard, Rachel Power, David Salisbury, Adrian Towse, Julie Roiz, Gabor Szabo, Jingyan Yang & Kinga Marczell. (2023) The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study. Vaccines 11:2, pages 234.
Crossref
Sean M. Bagshaw, Annalise Abbott, Sanjay Beesoon, Danny J. Zuege, Tracy Wasylak, Braden Manns & Thanh X. Nguyen. (2022) Avoidable intensive care unit resource use and costs of unvaccinated patients with COVID-19: a historical population-based cohort studyUtilisation et coûts évitables des ressources des unités de soins intensifs pour les patients non vaccinés atteints de COVID-19 : une étude de cohorte historique basée sur la population. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 69:11, pages 1399-1404.
Crossref
Lihui Zhou, Wenxin Yan, Shu Li, Hongxi Yang, Xinyu Zhang, Wenli Lu, Jue Liu & Yaogang Wang. (2022) Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies. Journal of Global Health 12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.